Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 234 results for "Tecfidera Treated Patients"

PML Death Reported in Patient Treated With Dimethyl Fumarate

—FDA today announced upcoming changes to the labeling of dimethyl fumarate after the death of the patient who was taking the drug for the treatment of multiple sclerosis (MS). According to FDA, the patient, a 54-year-old woman, was ... ASHP, 3 weeks ago
FDA News

FDA Issues Warning About Brain Infection Tied to Multiple Sclerosis Drug

The U.S. Food and Drug Administration (FDA) is warning that a patient with multiple sclerosis (MS) who was being treated with Tecfidera (dimethyl fumarate), developed a rare and serious brain infection called PML, and later died. As a result, ...
 Advance for Nurses3 weeks ago FDA Warns of Rare Brain Infection Associated With MS Drug Tecfidera  FDA News2 weeks ago FDA Issues Drug Safety Communication for Multiple Sclerosis Drug Tecfidera  HCPLive1 week ago FDA adds warning to Tecfidera label after patient death  Pharma Letter3 weeks ago

Biogen's Tecfidera Label Updated After Rare Brain Infection Case

The label for Biogen Idec Inc. (BIIB) 's multiple sclerosis drug Tecfidera will be updated with information about a patient who died of a rare brain infection while taking the medicine, U.S. regulators said today. The drug label, which gives ...
 Bloomberg3 weeks ago FDA amends label of Biogen Idec's Tecfidera to warn of a case of PML  FirstWord Pharma3 weeks ago Why Tecfidera Drug Label Is Updated...  RTTNews.com3 weeks ago

Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany

Tecfidera® is a product containing dimethyl fumarate (DMF) as the active ingredient for the treatment of MS. It was approved by the European Commission in January 2014. Worldwide sales of Tecfidera® as reported by Biogen Idec for the previous 4 ...
 Morningstar.com1 month ago Forward Pharma Files Lawsuit Against Biogen Over Tecfidera Sales In Germany  RTTNews.com1 month ago Forward Pharma : Sues Biogen Idec Over Tecfidera(R) Sales in Germany  4 Traders1 month ago Biogen: Nothing To Worry About  Seeking Alpha1 month ago

Biogen Falls On Patient's Death

Biogen stock traded down 5% yesterday following the announcement that a patient administered with Tecfidera, the company's MS drug, died after developing a brain infection Page 1 of 2 Click Ticker to See live coverage Biogen Idec Inc ( ...
 Bidness Etc1 month ago Hot Biogen shares fall after Tecfidera patient dies  CNBC2 months ago Biogen falls after Tecfidera patient dies  CNBC2 months ago

Biogen Falls After Patient Taking Top-Selling Tecfidera Dies

(Updates with closing shares in third paragraph.) Oct. 22 (Bloomberg) -- Shares of Biogen Idec Inc. fell the most in seven months after the company said a patient developed a rare brain infection and died while taking its top-selling multiple ...
 Washington Post2 months ago Health Exchange: Biogen shares drop on Tecfidera patient death  Austin American Statesman2 months ago Biogen Falls After Patient on Top-Selling Drug Dies  BusinessWeek2 months ago Why Biogen Idec Stock Shares Are Getting Pummeled Today  Nasdaq2 months ago
European Medicines Agency

Inform Patients of PML Case With Tecfidera in MS

The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) is advising physicians to inform their patients about a fatal case of progressive multifocal leukoencephalopathy (PML) in a patient being treated with dimethyl ...
 Medscape1 month ago News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 November 2014  European Medicines Agency1 month ago Highlights of EMA Pharmacovigilance unit meeting  Pharma Letter1 month ago

U.S. Claims Data Show That Biogen Idec's Tecfidera Captured Nearly Half of Second-Line Share Among Newly Diagnosed Multiple Sclerosis Patients

BURLINGTON, Mass. , Nov. 24, 2014 /PRNewswire/ --Decision Resources Group finds that, according to U.S. patient-level claims data, Biogen Idec's Tecfidera, the third-to-market oral disease modifying therapy (DMT) for multiple sclerosis (MS), ...
 Crawford Financial Planning4 weeks ago

Tecfidera now available from the NHS in England and Wales

From today Tecfidera , a treatment for relapsing remitting MS , will be made available on the NHS in England and Wales; it is already available in Northern Ireland and Scotland. Greater choice This means there are now 10 MS medicines available ...
 Multiple Sclerosis Society3 weeks ago
Motley Fool

3 Large Cap Biotech Stocks That Could Surprise Investors in 2015

Source: Celgene Corp. The volatility that comes with investing in biotech stocks can test the patience of even the most risk-tolerant investor. Many investors may be better served focusing on companies with proven track records of success rather ...
 Motley Fool1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less